<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">41025238</PMID><DateRevised><Year>2025</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1524-4628</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Sep</Month><Day>30</Day></PubDate></JournalIssue><Title>Stroke</Title><ISOAbbreviation>Stroke</ISOAbbreviation></Journal><ArticleTitle>Long-Term Follow-Up of Participants in the Taking Charge After Stroke Randomized Controlled Trial.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1161/STROKEAHA.125.052545</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The take charge intervention-a conversation-based, community intervention to improve motivation, improved independence, and physical health 12 months after stroke in 2 randomized controlled trials with 572 participants. This article reports long-term outcomes for the 400 participants in the TaCAS study (Taking Charge After Stroke).</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Follow-up study of a New Zealand multicenter, randomized, controlled, parallel-group trial. Outcomes were collected by postal questionnaire or telephone call. The TaCAS study recruited 400 participants discharged after stroke, randomized within 16 weeks to one of 3 groups: 1 session of the take charge intervention, 2 sessions 6 weeks apart, or no sessions (control). This study is of participants still alive and willing to answer a questionnaire 5 to 6 years after their index stroke, undertaken in 2022. The primary outcome was the Physical Component Summary of the Short Form 36, comparing the take charge intervention and control. Secondary outcomes were: Frenchay Activities Index; modified Rankin Scale (mRS); survival; and stroke recurrence. These outcomes were compared with those 12 months after stroke. Analysis was by ANOVA or logistic regression.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Mortality data were available for all 400 participants, and functional data for 204/297 (69%) of survivors. The mean difference (95% CI) in Physical Component Summary between take charge and control groups was 2.8 (-0.8 to 6.5) units, <i>P</i>=0.12, and for independence (modified Rankin Scale score, 0-2) the odds ratio (95% CI) was 0.56 (0.28-1.16), <i>P</i>=0.11, both favoring take charge with similar point estimates to those after 12 months. Differences between take charge and control participants for Frenchay Activities Index scores, survival, and stroke recurrence were small and nonsignificant.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">The clinically significant improvements in physical health and independence for take charge participants, observed at 12 months, were sustained 5 to 6 years after stroke, but no longer statistically significant.</AbstractText><AbstractText Label="REGISTRATION" NlmCategory="UNASSIGNED">URL: https://anzctr.org.au; Unique identifier: ACTRN12622000311752.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0131-5480</Identifier><AffiliationInfo><Affiliation>Medical Research Institute of New Zealand, Wellington (A.M., V.F., Z.J., S.J., A.E., G.S., A.S., H.M.N.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Vivian</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-0989-3672</Identifier><AffiliationInfo><Affiliation>Medical Research Institute of New Zealand, Wellington (A.M., V.F., Z.J., S.J., A.E., G.S., A.S., H.M.N.).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Calgary, ON, Canada (V.F.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joya</LastName><ForeName>Zamir</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0009-0000-0450-0369</Identifier><AffiliationInfo><Affiliation>Medical Research Institute of New Zealand, Wellington (A.M., V.F., Z.J., S.J., A.E., G.S., A.S., H.M.N.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joya</LastName><ForeName>Sajida</ForeName><Initials>S</Initials><Identifier Source="ORCID">0009-0003-2488-6395</Identifier><AffiliationInfo><Affiliation>Medical Research Institute of New Zealand, Wellington (A.M., V.F., Z.J., S.J., A.E., G.S., A.S., H.M.N.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eathorne</LastName><ForeName>Allie</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medical Research Institute of New Zealand, Wellington (A.M., V.F., Z.J., S.J., A.E., G.S., A.S., H.M.N.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weatherall</LastName><ForeName>Mark</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0051-9107</Identifier><AffiliationInfo><Affiliation>University of Otago, Wellington, New Zealand (M.W.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shortt</LastName><ForeName>Gabrielle</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Medical Research Institute of New Zealand, Wellington (A.M., V.F., Z.J., S.J., A.E., G.S., A.S., H.M.N.).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Victoria University of Wellington, New Zealand (G.S.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Semprini</LastName><ForeName>Alex</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0949-0555</Identifier><AffiliationInfo><Affiliation>Medical Research Institute of New Zealand, Wellington (A.M., V.F., Z.J., S.J., A.E., G.S., A.S., H.M.N.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gommans</LastName><ForeName>John</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-3750-765X</Identifier><AffiliationInfo><Affiliation>Hawkes Bay Hospital, Hastings, New Zealand (J.G.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McNaughton</LastName><ForeName>Harry</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-3030-6062</Identifier><AffiliationInfo><Affiliation>Medical Research Institute of New Zealand, Wellington (A.M., V.F., Z.J., S.J., A.E., G.S., A.S., H.M.N.).</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Stroke</MedlineTA><NlmUniqueID>0235266</NlmUniqueID><ISSNLinking>0039-2499</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">control groups</Keyword><Keyword MajorTopicYN="N">motivation</Keyword><Keyword MajorTopicYN="N">stroke rehabilitation</Keyword><Keyword MajorTopicYN="N">survivors</Keyword><Keyword MajorTopicYN="N">telephone</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>30</Day><Hour>5</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41025238</ArticleId><ArticleId IdType="doi">10.1161/STROKEAHA.125.052545</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>